Learn more about the impact of perinatal depression on child neurodevelopment, new rapid-acting treatments for PPD, and new data reshaping how we treat menopausal symptoms.
This week’s list spans antidepressant safety, benefits of psychotropic medication continuation on postpartum self-harm risk, anti-seizure medications and congenital malformations, and new approaches to PPD screening.
This week’s roundup covers prenatal SARS-CoV-2 exposure and child neurodevelopment, cannabis use in pregnancy and related risks, and estradiol-linked mood changes during menopause.
Every week we review the most recent publications in women’s mental health.
Every week we review the most recent publications in women’s mental health.
Lavender, used historically for anxiety, stress, depression, and sleep, may provide benefits through aromatherapy or oral forms. Evidence supports potential effects, though safety and efficacy in pregnancy and breastfeeding remain unclear.
All women are at risk for depression during pregnancy and the postpartum period, and there is growing evidence to suggest that poor sleep during pregnancy and the postpartum period may be a risk factor for [...]
Peri- and post-menopausal women frequently complain of insomnia or poor sleep quality. Sleep disturbance is often attributed to nocturnal hot flashes; however, a sizeable proportion of menopausal women may have a primary sleep disorder. Â Â Â As [...]
Next week we will be reviewing two important articles which look at the effects of maternal depression on the developing brain of the child: one from Posner and colleagues and another from Lebel and colleagues. [...]
Sleep disturbance is commonly reported during pregnancy. A recent study looked at the impact of sleep quality on risk for depression.
